Search

everythinglearnresearchcommunity

for

Search:↓

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Certain gene variations are not a major cause of male infertility in Nigerian men.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

A substance called TCQA could potentially darken hair by activating certain genes and increasing melanin.

Androgen receptors found in monkey scalps, similar to humans, affect hair growth.

Skin RAGE levels are linked to inflammation and cell death.

PGF_2α receptors in human eyelids are found in specific parts of hair follicles, explaining eyelash changes with glaucoma treatment.

Women with hair loss have more androgen receptors in certain hair follicles.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Higher levels of the DP2 receptor may lead to hair loss.

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Lowering testosterone speeds up wound healing in male mice.

Activating TRPV3 stops human hair growth.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Local injections of nanosized rhEPO can speed up skin healing and improve quality after deep second-degree burns.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Drinking sweetened tea and late bedtimes increase the risk of hair loss in women.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.